We evaluated the time course of osteoinduction by an adenoviral vector, AxC
AOBMP-2, in normal rats (Group I) and 2 immunosuppressed groups (Groups II
and III). Immunosuppression was induced by 125 mg/kg of cyclophosphamide in
jected intraperitoneally the day before vector injection. Groups I and III
received a high dose of AxCAOBMP-2 (25 mul; 8.75 x 10(8) pfu) and Group II
a low dose (5 mul; 1.75 x 10(8) pfu). Each dose of AxCAOBMP-2 was injected
into the right calf muscle of rats. On days 7, 14 and 21 postinjection, the
osteoinducive activity in each group was investigated radiologically, hist
ologically, immunohistochemically and biochemically. Osteoinduction was obs
erved only in Groups II and III on days 14 and 21. The activity of osteoind
uction in Group III was higher than that in Group II. There was little diff
erence in the expression of LacZ between Groups I and III on day 3. However
, there was a marked difference in BMP-2 protein expression between Groups
I and III on day 7 postinjection. We speculated that the reason for this wa
s that most of the infected cells were eliminated by the immune system of t
he host from days 3 to 7. These results suggest that gene therapy with AxCA
OBMP-2 under transient immunosuppression may be useful for bone reconstruct
ion. (C) 2001 Elsevier Science Inc. All rights reserved.